Drug Trial Radar · NCT03337308
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
Last checked: Nov 19, 2026Latest source record: Apr 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
382
Actual
Start
Oct 23, 2017
Primary completion
Jun 18, 2018
Study completion Jul 18, 2018
Sponsor
- Lead sponsor
- Esperion Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if Bempedoic Acid (BA) + Ezetimibe (EZE) in a fixed-dose combination (FDC) is effective and safe versus its individual components and placebo in patients with elevated LDL cholesterol treated with maximally tolerated statin therapy.
Conditions
- Hyperlipidemias
Interventions
Bempedoic Acid + Ezetimibe Fixed-Dose CombinationCombination product
bempedoic acid + ezetimibe FDC 180 mg/10 mg tablet
Bempedoic AcidDrug
bempedoic acid 180 mg tablet
EzetimibeDrug
ezetimibe 10 mg overencapsulated tablet
PlacebosDrug
placebo tablet or capsule to match bempedoic acid + ezetimibe fixed-dose combination (FDC) 180 mg/10 mg tablet, or bempedoic acid 180 mg tablet, or ezetimibe 10 mg capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline to Week 12 in Low-density Lipoprotein Cholesterol (LDL-C)Time frame: Baseline; Week 12
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
PMG Research of McFarland
Ames, Iowa
Foundation Cardiology
Nashua, New Hampshire
PMG Research of Piedmont Healthcare
Statesville, North Carolina
PMG Research of Wilmington
Wilmington, North Carolina
PMG Research of Knoxville
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.